• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIU Qi,MA Chao,SU Xiaohui,XU Hui.Exploration and reflection on the implementation strategy of remote supervision in the production process of medical device manufacturers in the context of the artificial intelligence[J].Journal Of Pharmaceutical Research,2025,44(8):774-778,785[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2013times   Download 723次 QR Code for this article
Scan with your phone!
人工智能时代背景下医疗器械生产企业远程监管的探索与思考及相关实施策略
刘锜1,马超2,苏小徽1,许珲3
Font:Larger+|Default|Smaller-
(1.山东省市场监管监测中心,山东 济南 250012;2.山东省食品药品检验研究院,山东 济南 250101;3.山东省医疗器械和药品包装检验研究院,山东 济南 250101)
摘要:
人工智能赋能的生产环节远程监管,是当前政府创新监管模式、加强数字政府建设、实现智慧监管的关键路径。针对医疗器械行业传统现场检查受地域、空间、人力物力限制的痛点,本文聚焦人工智能时代背景下如何有效实施对该行业生产环节的远程监管。通过分析行业监管现状与难点,借鉴国内外多领域远程监管实践经验及人工智能应用成效,本研究旨在探索并提出契合医疗器械行业特点的远程监管方法与实施策略。
关键词:  医疗器械监管  远程监管  智慧监管  监管创新  人工智能
DOI:10.13506/j.cnki.jpr.2025.08.008
基金项目:
Publication Date:August 25, 2025
Exploration and reflection on the implementation strategy of remote supervision in the production process of medical device manufacturers in the context of the artificial intelligence
LIU Qi1,MA Chao2,SU Xiaohui1,XU Hui3
(1.Shandong Market Regulation Monitoring Center,Jinan 250012,China;2.Shandong Institute for Food and Drug Control,Jinan 250101,China;3.Shandong Institute of Medical Device and Pharmaceutical Packaging Inspection,Jinan 250101,China)
Abstract:
AI-enabled remote supervision of production processes represents a critical pathway for the government's innovative regulatory models, strengthening digital government construction, and achieving intelligent supervision. Addressing the pain points of traditional on-site inspections in the medical device industry—such as geographical, spatial, and resource constraints—this paper focuses on how to effectively implement remote supervision of production processes within this sector in the era of artificial intelligence. By analyzing the current state and challenges of industry supervision, and drawing on practical remote supervision experience from diverse fields both domestically and internationally, as well as the application outcomes of AI, this study aims to explore and propose remote supervision methods and implementation strategies tailored to the characteristics of the medical device industry.
Key words:  Supervision of medical device manufacturers  Remote supervision  Intelligent supervision  Government regulatory innovation  Artificial intelligence
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.